Efficacy of Docetaxel, Trastuzumab Combined with Pyrotinib in the Treatment of Patients with Advanced HER-2 Positive Breast Cancer

Efficacy of Docetaxel, Trastuzumab Combined with Pyrotinib in the Treatment of Patients with Advanced HER-2 Positive Breast Cancer

XU Zhitan

PDF(1012 KB)

PDF(1012 KB)

Chinese And Foreign Medical Research ›› 2023, Vol. 21 ›› Issue (27) : 23-27. DOI: 10.14033/j.cnki.cfmr.2023.27.006

Clinical practice

Efficacy of Docetaxel, Trastuzumab Combined with Pyrotinib in the Treatment of Patients with Advanced HER-2 Positive Breast Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 21(27): 23-27 https://doi.org/10.14033/j.cnki.cfmr.2023.27.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1012 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉